Correlation Between Deluxe and Quantum BioPharma

Can any of the company-specific risk be diversified away by investing in both Deluxe and Quantum BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Deluxe and Quantum BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Deluxe and Quantum BioPharma, you can compare the effects of market volatilities on Deluxe and Quantum BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Deluxe with a short position of Quantum BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Deluxe and Quantum BioPharma.

Diversification Opportunities for Deluxe and Quantum BioPharma

-0.46

Correlation Coefficient

Deluxe  Quantum BioPharma

Very good diversification

The 3 months correlation between Deluxe and Quantum is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Deluxe and Quantum BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quantum BioPharma and Deluxe is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Deluxe are associated (or correlated) with Quantum BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quantum BioPharma has no effect on the direction of Deluxe i.e., Deluxe and Quantum BioPharma go up and down completely randomly.

Pair Corralation between Deluxe and Quantum BioPharma

Considering the 90-day investment horizon Deluxe is expected to generate 0.27 times more return on investment than Quantum BioPharma. However, Deluxe is 3.67 times less risky than Quantum BioPharma. It trades about -0.12 of its potential returns per unit of risk. Quantum BioPharma is currently generating about -0.03 per unit of risk. If you would invest  2,299  in Deluxe on October 26, 2024 and sell it today you would lose (89.00) from holding Deluxe or give up 3.87% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Deluxe  vs.  Quantum BioPharma

Deluxe

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Deluxe are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Deluxe showed solid returns over the last few months and may actually be approaching a breakup point.

Quantum BioPharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Quantum BioPharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Deluxe and Quantum BioPharma

The main advantage of trading using opposite Deluxe and Quantum BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Deluxe position performs unexpectedly, Quantum BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quantum BioPharma will offset losses from the drop in Quantum BioPharma's long position.

The idea behind Deluxe and Quantum BioPharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.